Evidence map›Paper›PMID 32932010›Full record

ArticleEuropean journal of oncology nursing : the official journal of European Oncology Nursing Society2020

Exploring the experiences of patients, general practitioners and oncologists of prostate cancer follow-up: A qualitative interview study.

Sally Taylor, Helen Johnson, Sara Peat, Jane Booker, Janelle Yorke

Abstract read
In one paragraph

Article in European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sally TaylorThe Christie Patient Centred Research Team, The Christie School of Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK. Electronic address: sally.taylor38@nhs.net.
Helen JohnsonThe Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.
Sara PeatThe Christie Patient Centred Research Team, The Christie School of Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.
Jane BookerThe Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.
Janelle YorkeThe Christie Patient Centred Research Team, The Christie School of Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK; Division of Nursing, Midwifery and Social Work, School of Health Sciences, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo examine the experiences of patients and healthcare professionals of prostate cancer follow-up in primary care and to identify areas where current policy and practice could be improved.

methodsSemi-structured interviews with patients, GPs and oncologists explored experiences of prostate cancer follow-up. Interviews were audio recorded and transcribed verbatim. Data were analysed using thematic analysis. The three participant groups were analysed as individual datasets but the same key themes were evident across the groups.

results14 patients, 6 GPs and 5 oncologists were interviewed. Four main themes were identified: Experience of current practice; Knowledge and understanding of prostate cancer follow up; Disparity of processes and pathways; Unclear roles and responsibilities.

conclusionsFindings from this study highlight the variation in the approach to prostate specific antigen monitoring and emphasise the lack of clear policies and practices. The lack of clarity around existing follow up and monitoring processes could cause delays in the diagnosis of recurrence. There is a need for a new and improved pathway for prostate cancer follow up. The pathway should include clear and concise guidance for patients, primary care and secondary care and all relevant parties need to understand what their role is within the pathway.

Indexed as

Attitude of Health PersonnelAdultAgedAged, 80 and overFollow-Up StudiesGeneral PractitionersHumansMaleMiddle AgedNeoplasm Recurrence, LocalOncologistsPatient SatisfactionPrimary Health CareProstatic NeoplasmsQualitative ResearchFollow upOncologyPrimary careProstate cancerQualitative

Identifiers

PMID32932010
PMCPMC7395829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.